·         Seeking growth investment

The Company delivers a medical office-based system (console & catheters) that thermally treats two urological diseases: bladder cancer and chronic prostatitis. The Company future solutions will be for interstitial cystitis and overactive bladder. Each of the above conditions requires multiple procedures for each patient.

The Company's proprietary non-ablative high temperature (hyperthermia) innovative technologies, DuoThermia and UniThermia, are covered by issued and pending patents. DuoThermia, the free circulation of heated saline or drug-solution in the bladder and a heated balloon in the urethra and UniThermia, the uniform hyperthermia (with or without drug) in the bladder alone, have unique advantages over current thermal-treatment devices in urology.

The system has the CE mark and Israeli approvals. It is already sold in Europe and Israel.

Interested in this opportunity ? Contact us now !